With China actively promoting VBP (volume based procurement) and DRG (Diagnosis Related Group) in the health care sector, the companies in the health care field should have a clear picture for the launched products and the projects in the pipeline from the health economy perspective. For the overseas’ health care companies, if you want to know more about China’s policy in the next step for VBP and DRG, you can contact Angine for more information, and and we will work with our China Health Economy Expert to give your the following proposals and solutions based on the specified products.
China’s VBP and DRG policy, now and next step
Value Proposition under DRG
How to Price Your Products?
Digital Health Approach